Skip to content
Wednesday, October 14, 2026
Digital Fokuspunkt

Patients Coming Off Weight-Loss Medications Regain Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise

Illustration of medical injection and scale
Weight management often requires ongoing approaches.

A recent study reveals that individuals who stop using blockbuster slimming jabs like Wegovy and Mounjaro tend to recover shed pounds far faster than those who halt traditional lifestyle programs.

Findings released in a leading medical journal points out that while obese people can lose substantial amounts of their body weight while using the jabs, the weight returns at an average rate of 0.8 kg per month once they quit.

"Users purchasing these treatments must be aware of the danger of fast rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.

That rate of regain means a reversion to original mass within about one and a half years.

Comparing Approaches

The study, which examined 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.

Scientists point out that people who shed pounds through dieting typically experience a slower weight regain—around 0.1 kg a month—post-intervention.

The Reason for the Rapid Regain

Doctors believe the mode of action of the jabs is key to understanding the heightened weight return.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which controls hunger.

"Artificially providing the hormone levels far above than normal could lead to the system to generate a reduced amount of its endogenous hormone, and could lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication results in appetite is no longer kept in check, making overeating far more likely."

An Ongoing Disease?

Health authorities recommend the jabs for people with obesity-related health risks, alongside recommended lifestyle changes.

Many experts argue that, considering the likelihood of weight regain, the treatment might need to be ongoing.

This opinion is reinforced by pharmaceutical companies, who say that the findings "underscore the chronic character of excess weight," similar to managing diseases like diabetes.

Patient Testimonies

Individuals who have come off the jabs describe a powerful return of appetite.

"It was like a trigger that goes on and you're instantly ravenous," described one woman.

This difficulty is exacerbated if users have not adopted permanent dietary or behavioural modifications during treatment.

Widespread Use

Survey data indicate that millions of people in the UK have tried weight-loss jabs in the past year, with demand remaining high.

  • Adoption is greater among women than males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the medications through private healthcare rather than public health services.

In conclusion, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a magic fix and maintained weight loss relies on ongoing lifestyle management.

By

Katrina Greene

A digital strategist with over a decade of experience in SEO and content marketing, passionate about helping businesses thrive online.

Digital Fokuspunkt

Type to search articles.